Anitoa is a professional R&D and manufacturing company of molecular diagnostic qPCR instruments and reagents, with independent intellectual property rights of core chip technology, optical technology, rapid heating, microfluidic control and supporting reagents and other patented technologies, so that the instruments developed by Anitoa are characterized by quick and easy small instruments, allowing the development of expensive and complex large PCR instruments into truly portable POCT products. Anitoa is developing the "Automatic Portable qPCR Instrument" and "Quick qPCR Instrument", which will be the most important products to popularize molecular diagnostics to the general public.
2012, Anitoa, a brand of molecular diagnostic products, was founded in Silicon Valley, USA.
2014, Anitoa developed one of its core technologies, "Ultra-Low-Light CMOS Image Sensor (CIS) Chips", which was successfully released;
2016, Anitoa started the independent research and development of small qPCR instrument from the basic to the whole machine;
2018, Anitoa Maverick qPCR instrument was validated in small scale market;
2020, the company's products Maverick series MQ1, MQ4 received international market orders.
2021, the company will establish its own production system and obtain ISO13485, ISO9001, CEIVD and FDA certifications;
2022, the first generation of the whole series of products will be launched gradually, the second generation of products will be verified, and the third generation of fully automated products will be developed.
Anitoa is a professional R&D and manufacturing company of molecular diagnostic qPCR instruments and reagents, with independent intellectual property rights of core chip technology, optical technology, rapid heating, microfluidic control and supporting reagents and other patented technologies, so that the instruments developed by Anitoa are characterized by quick and easy small instruments, allowing the development of expensive and complex large PCR instruments into truly portable POCT products. Anitoa is developing the "Automatic Portable qPCR Instrument" and "Quick qPCR Instrument", which will be the most important products to popularize molecular diagnostics to the general public.
2012, Anitoa, a brand of molecular diagnostic products, was founded in Silicon Valley, USA.
2014, Anitoa developed one of its core technologies, "Ultra-Low-Light CMOS Image Sensor (CIS) Chips", which was successfully released;
2016, Anitoa started the independent research and development of small qPCR instrument from the basic to the whole machine;
2018, Anitoa Maverick qPCR instrument was validated in small scale market;
2020, the company's products Maverick series MQ1, MQ4 received international market orders.
2021, the company will establish its own production system and obtain ISO13485, ISO9001, CEIVD and FDA certifications;
2022, the first generation of the whole series of products will be launched gradually, the second generation of products will be verified, and the third generation of fully automated products will be developed.